Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001516551-24-000112
Filing Date
2024-11-07
Accepted
2024-11-07 16:18:49
Documents
5
Effectiveness Date
2024-11-07

Document Format Files

Seq Description Document Type Size
1 S-8 skye-11072024_sx8arplan.htm S-8 58504
2 EX-FILING FEES ex107filingfeetable1.htm EX-FILING FEES 14669
3 EX-5.1 ex51opinionoffennemorecrai.htm EX-5.1 11971
4 EX-23.2 ex232consentofmarcumllp1.htm EX-23.2 2472
5 fennemore.jpg GRAPHIC 1871
  Complete submission text file 0001516551-24-000112.txt   91655
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

EIN.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-283068 | Film No.: 241436101
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)